Leaflet LOSMINA 4000UI (40mg)/0.4ml solution for injection in pre-filled syringe

Indicated for: prevention and treatment of thromboembolism

Route of administration: injectable

Substance: enoxaparin (anticoagulant)

ATC: B01AB05 (Blood and blood forming organs | Antithrombotic agents | Heparin group)

Precautions:
Dose adjustment in renal impairment
Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Bleeding risk
Bleeding risk

This medicine may increase the risk of bleeding.

Enoxaparin is an anticoagulant medication used to prevent and treat blood clots (thrombosis). It belongs to the class of low molecular weight heparins (LMWH) and works by inhibiting clotting factors, particularly thrombin and factor Xa, thereby preventing the formation of blood clots.

Enoxaparin is indicated for the prevention of deep vein thrombosis (DVT), pulmonary embolism (PE), and thrombotic complications in patients with unstable angina or non-ST-elevation myocardial infarction (NSTEMI). It is also used to treat existing thrombosis and to prevent clot formation in immobilized patients or those undergoing surgery.

The medication is administered as subcutaneous injections, usually in the abdominal area, as directed by a healthcare provider. Side effects may include bleeding, hematomas at the injection site, nausea, or, rarely, allergic reactions and heparin-induced thrombocytopenia (HIT). It is important to use enoxaparin as prescribed and to inform the healthcare provider about other medications or pre-existing conditions to avoid complications.

General data about LOSMINA 4000UI (40mg)/0.4ml

  • Substance: enoxaparin
  • Date of latest medicines list: 01-06-2026
  • Product code: W64175007
  • Concentration: 4000UI(40mg) / 0.4ml
  • Pharmaceutical form: solution for injection in pre-filled syringe
  • Quantity: 2
  • Product type: Generic medicine
  • Price: 33.59 RON
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: ROVI CONTRACT MANUFACTURING, S.L. - SPANIA
  • Holder: LABORATORIOS FARMACEUTICOS ROVI, S.A. - SPANIA
  • Number: 10384/2017/07
  • Shelf life: 3 years

Pharmaceutical forms available for enoxaparin

Concentrations available for enoxaparin

  • 10000UI(100mg)/1.0ml
  • 10000UI(100mg)/1ml
  • 100mg/ml
  • 12000UI(120mg)/0.8ml
  • 15000UI(150mg)/1ml
  • 2000ui anti-Xa/0.2ml
  • 2000UI(20mg)/0.2ml
  • 4000ui anti-Xa/0.4ml
  • 4000UI(40mg)/0.4ml
  • 6000ui anti-Xa/0.6ml
  • 6000UI(60mg)/0.6ml
  • 8000ui anti-Xa/0.8ml
  • 8000UI(80mg)/0.8ml

Compensation lists for LOSMINA 4000UI (40mg)/0.4ml Laboratorios Farmacéuticos

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

33.59 RON

12.07 RON

21.52 RON

NHP 10 (C2) - Replacement of renal function in patients with chronic renal failure

Price

Copayment

Patient

33.59 RON

29.23 RON

4.36 RON

NHP 9.3 (C2) - Liver Transplant

Price

Copayment

Patient

33.59 RON

29.23 RON

4.36 RON

NHP 9.4 (C2) - Kidney transplant, combined kidney and pancreas transplant

Price

Copayment

Patient

33.59 RON

29.23 RON

4.36 RON

NHP 9.6 (C2) - Lung transplant

Price

Copayment

Patient

33.59 RON

29.23 RON

4.36 RON